Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Mesothelin

MSLN (Mesothelin) is a cell surface glycoprotein predominantly overexpressed in mesothelial cells and various tumour cells, including ovarian and pancreatic cancers. MSLN plays a crucial role in cell-cell adhesion and signal transduction. Due to its high expression in tumour cells, MSLN has emerged as a prominent target for tumour diagnosis and therapy. High MSLN expression correlates with tumour aggressiveness, drug resistance, and poor prognosis.

Amatuximab
T76671931402-35-6
Amatuximab (MORab-009) is a humanized chimeric IgG1/k monoclonal antibody targeting cell surface mesothelin (MSLN) with antitumor activity for the treatment of solid tumors.
  • $198
In Stock
Size
QTY
BMS-986148
T9901A-075
BMS-986148 is a CHO-expressed humanized antibody-drug coupling targeting mesothelin-expressing cells for cytotoxic load delivery.
  • $450
In Stock
Size
QTY
Anti-Human MSLN Antibody (Clone HN1)
T9901A-825
Anti-Human MSLN Antibody (Clone HN1) is a humanised monoclonal antibody targeting MSLN (Mesothelin), composed of the mesothelin-specific HN1, which blocks the interaction between MSLN and CA125 with cancer cells, and can be used for cancer research.
  • $195
In Stock
Size
QTY
Anti-Mesothelin Antibody
T9901A-1398
Anti-Mesothelin Antibody is a human-derived antibody expressed in CHO cells, specifically targeting Mesothelin. It consists of an huIgG1 heavy chain and an huκ light chain, with an estimated molecular weight (MW) of 150 kDa. For its isotype control, refer to HumanIgG1kappa, Isotype Control.
    Inquiry